Evidence map›Paper›PMID 39994008›Full record

Trial reportEuropean journal of applied physiology2025

Effects of a single dose of a betalain-rich concentrate on determinants of running performance and recovery muscle blood flow: a randomized, triple-blind, placebo-controlled, crossover trial.

Steven Vitti, Michael Bruneau, Leah Bisgrove, Samuel Grey, Sarah Levine, Craig Mattern, Justin Faller

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in European journal of applied physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Steven VittiHealth Sciences Department, Drexel University, Philadelphia, PA, USA. sv675@drexel.edu.ORCID http://orcid.org/0000-0001-5446-7309
Michael BruneauHealth Sciences Department, Drexel University, Philadelphia, PA, USA.
Leah BisgroveDepartment of Kinesiology, Sport Studies & Physical Education, SUNY Brockport, Brockport, NY, USA.
Samuel GreyDepartment of Kinesiology, Sport Studies & Physical Education, SUNY Brockport, Brockport, NY, USA.
Sarah LevineDepartment of Kinesiology, Sport Studies & Physical Education, SUNY Brockport, Brockport, NY, USA.
Craig MatternDepartment of Kinesiology, Sport Studies & Physical Education, SUNY Brockport, Brockport, NY, USA.
Justin FallerDepartment of Kinesiology, Sport Studies & Physical Education, SUNY Brockport, Brockport, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed to examine the effects of a single dose of a betalain-rich concentrate (BRC) on determinants of running performance and recovery lactate clearance.

methodsIn this a randomized, triple-blind, placebo-controlled, crossover trial, 17 male recreational runners (Age: 19.0 ± 1.0 years; Height: 176.8 ± 6.2 cm; Weight: 70.62 ± 8.1 kg; Body fat: 12.8 ± 0.03%; VO

resultsBRC resulted in lower heart rate (HR) at velocities corresponding to 80% of VO

conclusionsA single dose of BRC did not enhance RE or VO

Indexed as

Athletic PerformanceBetalainsMuscle, SkeletalRunningAdultCross-Over StudiesHeart RateHumansLactic AcidMaleOxygen ConsumptionRegional Blood FlowYoung AdultBetalainsLactic AcidBeetrootBetalainsBlood flowRunning economy

Identifiers

PMID39994008
PMCPMC12227450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.